Key Insights

Highlights

Treatment Research

2 treatments under study, led by Technetium Scitigraphy

Research Leaders

13 sponsors active, led by Wake Forest University

Related Conditions

Often studied with 6 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

2Total
Not Applicable (2)

Trial Status

Recruiting2
Unknown1

Clinical Trials (3)

Showing 3 of 3 trials
NCT07287943Not ApplicableRecruiting

To Study the Efficacy and Safety of Medtronic 780G Insulin Pump in People With Gastroparesis and Type 1 Diabetes.

NCT05846802Recruiting

Gastroparesis Registry 4

NCT05717205Not ApplicableUnknownPrimary

Pathophysiology of Diabetic Gastroparesis

Showing all 3 trials

Research Network

Common Treatments

  • Technetium Scitigraphy1
  • Medtronic 780g Aid1

Active Sponsors

  • Wake Forest University1
  • Medtronic1
  • Viral N. Shah1
  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1
  • Zealand University Hospital1

Top Investigators

Related Conditions

  • Functional Disorder Of Gastrointestinal Tract1
  • Gastrointestinal Disorder1
  • Gastroparesis Nondiabetic1
  • Gastroparesis Due To Diabetes Mellitus Type Ii1
  • Gastroparesis1

Activity Timeline